Imaging features of extranodal involvement in paediatric Hodgkin lymphoma

Suzanne Spijkers; Annemieke S Littooij; Paul D Humphries; Marnix G E H Lam; Rutger A J Nievelstein

doi:10.1007/s00247-018-4280-z

Imaging features of extranodal involvement in paediatric Hodgkin lymphoma

Pediatr Radiol. 2019 Feb;49(2):266-276. doi: 10.1007/s00247-018-4280-z. Epub 2018 Dec 5.

Authors

Suzanne Spijkers¹, Annemieke S Littooij², Paul D Humphries^{3

4}, Marnix G E H Lam², Rutger A J Nievelstein²

Affiliations

¹ Department of Radiology and Nuclear Medicine, University Medical Center Utrecht/Wilhelmina Children's Hospital, Heidelberglaan 100, 3584, CX, Utrecht, The Netherlands. suzannespijkers@outlook.com.
² Department of Radiology and Nuclear Medicine, University Medical Center Utrecht/Wilhelmina Children's Hospital, Heidelberglaan 100, 3584, CX, Utrecht, The Netherlands.
³ Department of Specialist Radiology, University College London Hospital, London, UK.
⁴ Department of Radiology, Great Ormond Street Hospital for Children, London, UK.

Abstract

Detecting extranodal disease in paediatric Hodgkin lymphoma is of great importance for both treatment and prognosis. Different imaging techniques can be used to identify these extranodal sites. This pictorial essay provides an overview of imaging features of extranodal disease manifestation in paediatric Hodgkin lymphoma.

Keywords: 18F-fluoro-2-deoxy-D-glucose; Adolescents; Children; Diffusion-weighted magnetic resonance imaging; Extranodal lymphoma; Hodgkin lymphoma; Positron emission tomography/computed tomography; Whole-body magnetic resonance imaging.

Publication types

Review

MeSH terms

Child
Contrast Media
Hodgkin Disease / diagnostic imaging*
Hodgkin Disease / pathology
Humans
Lymph Nodes / diagnostic imaging
Lymph Nodes / pathology
Magnetic Resonance Imaging
Multimodal Imaging*
Neoplasm Staging
Positron Emission Tomography Computed Tomography
Radiopharmaceuticals
Whole Body Imaging

Substances

Contrast Media
Radiopharmaceuticals